Qiong Wu

Dr. Qiong Wu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2020 in EJNMMI Physics
Verified
Journal Article
Open access
PDF file
LDLiang Ding
Liang Ding
QWQiong Wu
Qiong Wu
QWQun Wang
Qun Wang
YLYamei Li
Yamei Li
RPRichard M. Perks
Richard M. Perks
LZLiang Zhao
Liang Zhao
This article presents a new perspective on the development of inorganic scintillator-based fiber dosimeters (IOSFDs) for medical radiotherapy dosimetry (RTD) focusing on real-time in vivo dosimetry. The scintillator-based optical fiber dosimeters (SFD) are compact, free of electromagnetic interference, radiation-resistant, and robust. They have shown great potential for real-time in vivo RTD. Compared with organic scintillators (OSs), inorganic scintillators (IOSs) have larger X-ray absorption and higher light output. Variable IOSs with maximum emission peaks in the red part of the spectrum offer convenient stem effect removal. This article outlines the main advantages and disadvantages of utilizing IOSs for SFD fabrication. IOSFDs with different configurations are presented, and their use for dosimetry in X-ray RT, brachytherapy (BT), proton therapy (PT), and boron neutron capture therapy (BNCT) is reviewed. Challenges including the percentage depth dose (PDD) deviation from the standard ion chamber (IC) measurement, the angular dependence, and the Cherenkov effect are discussed in detail; methods to overcome these problems are also presented.

7 December 2016 in RSC Advances
Verified
Journal Article
Open access
PDF file
QWQiong Wu
Qiong Wu
XLXue-Li Lai
Xue-Li Lai
HZHong-Xia Zhao
Hong-Xia Zhao
ZZZhen-Yu Zhu
Zhen-Yu Zhu
ZHZhan-Ying Hong
Zhan-Ying Hong
YCYifeng Chai
Yifeng Chai
Anemia is an almost universal complication of chronic kidney disease (CKD), and nearly all patients with end-stage renal disease (ESRD) and approximately 70% of those with earlier stages of CKD receive treatment for anemia.